These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35808972)

  • 1. Subacute cutaneous lupus erythematosus induced by Capecitabine: Confocal microscopy and dermoscopy findings.
    Montero-Menárguez J; Gutiérrez-Collar C; Puerta-Peña M; Mitsunaga K; Peralto JLR; Velasco-Tamariz V
    Dermatol Ther; 2022 Sep; 35(9):e15705. PubMed ID: 35808972
    [No Abstract]   [Full Text] [Related]  

  • 2. The concurrence of subacute cutaneous lupus erythematosus and hand-foot syndrome in a patient undergoing capecitabine chemotherapy.
    Li Z; Jiang N; Xu Y
    Australas J Dermatol; 2016 Feb; 57(1):e14-6. PubMed ID: 25495707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capecitabine-induced Subacute Cutaneous Lupus Erythematosus.
    Rocha A; Almeida HL; Zerwes G; Oliveira Filho UL
    An Bras Dermatol; 2019; 94(5):618-619. PubMed ID: 31777367
    [No Abstract]   [Full Text] [Related]  

  • 4. [Capecitabine-induced subacute cutaneous lupus: a case report].
    Fongue J; Meunier B; Lardet D; Dicostanzo MP; Rouby F; Terrier JP; Harlé JR; Richard MA; Chiche L
    Ann Dermatol Venereol; 2014 Oct; 141(10):593-7. PubMed ID: 25288062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic 5-fluorouracil induced lupus erythematosus: a review of the literature.
    Shakhbazova A; Marsch AF
    Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine.
    Weger W; Kränke B; Gerger A; Salmhofer W; Aberer E
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S4-6. PubMed ID: 18625380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subacute cutaneous lupus erythematosus associated with capecitabine monotherapy.
    Fernandes NF; Rosenbach M; Elenitsas R; Kist JM
    Arch Dermatol; 2009 Mar; 145(3):340-1. PubMed ID: 19289781
    [No Abstract]   [Full Text] [Related]  

  • 8. Capecitabine-induced subacute cutaneous lupus erythematosus: report of a case with positive rechallenge test.
    Ko JH; Hsieh CI; Chou CY; Wang KH
    J Dermatol; 2013 Nov; 40(11):939-40. PubMed ID: 24111883
    [No Abstract]   [Full Text] [Related]  

  • 9. Subacute cutaneous lupus erythematosus induced by capecitabine.
    Floristan U; Feltes RA; Sendagorta E; Feito-Rodriguez M; Ramírez-Marín P; Vidaurrázaga C; Casado-Jiménez M
    Clin Exp Dermatol; 2009 Oct; 34(7):e328-9. PubMed ID: 19456774
    [No Abstract]   [Full Text] [Related]  

  • 10. Subacute cutaneous lupus erythematosus after treatment with capecitabine.
    Kindem S; Llombart B; Requena C; Ruiz A; Traves V; Guillen C; San Martin O
    J Dermatol; 2013 Jan; 40(1):75-6. PubMed ID: 22937906
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-induced subacute cutaneous lupus erythematosus--filling the gap in knowledge: comment on "subacute cutaneous lupus erythematosus induced by chemotherapy".
    Callen JP
    JAMA Dermatol; 2013 Sep; 149(9):1075-6. PubMed ID: 23842706
    [No Abstract]   [Full Text] [Related]  

  • 12. Subacute cutaneous lupus erythematosus induced by capecitabine: 5-FU was innocent.
    Kim WI; Kim JM; Kim GW; Mun JH; Song M; Kim HS; Kim BS; Kim MB; Ko HC
    J Eur Acad Dermatol Venereol; 2016 Nov; 30(11):e163-e164. PubMed ID: 26551520
    [No Abstract]   [Full Text] [Related]  

  • 13. The combined role of clinical, reflectance confocal microscopy and dermoscopy applied to chronic discoid cutaneous lupus and subacutus lupus erythematosus: A case series and literature review.
    Mazzilli S; Vollono L; Diluvio L; Botti E; Costanza G; Campione E; Donati M; Prete MD; Orlandi A; Bianchi L; Gonzalez S
    Lupus; 2021 Jan; 30(1):125-133. PubMed ID: 33019879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Subacute cutaneous lupus erythematosus induced by 5-fluorouracil].
    Baggio R; Chavel P; Tisseau L; Darrieux L; Safa G
    Presse Med; 2017 Sep; 46(9):876-879. PubMed ID: 28666566
    [No Abstract]   [Full Text] [Related]  

  • 15. Eruptive palmoplantar lesions induced by capecitabine: report of a case evaluated with dermoscopy.
    García-Lozano JA; Ocampo-Candiani J; González-Ramírez RA
    Cir Cir; 2019; 87(S1):38-42. PubMed ID: 31501632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Capecitabine-induced eruptive acral hyperpigmentation: Clinical and dermoscopic evaluation of two cases.
    Peccerillo F; Pampena R; Giannetti L; Pellacani G; Longo C
    Dermatol Ther; 2019 May; 32(3):e12853. PubMed ID: 30748073
    [No Abstract]   [Full Text] [Related]  

  • 17. Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases.
    Callen JP; Hughes AP; Kulp-Shorten C
    Arch Dermatol; 2001 Sep; 137(9):1196-8. PubMed ID: 11559217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hair and Scalp Changes in Cutaneous and Systemic Lupus Erythematosus.
    Udompanich S; Chanprapaph K; Suchonwanit P
    Am J Clin Dermatol; 2018 Oct; 19(5):679-694. PubMed ID: 29948959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermoscopy in the diagnosis of generalized acute cutaneous lupus erythematosus.
    Behera B; Kumari R; Mohan Thappa D; Gochhait D; Ayyanar P
    Int J Dermatol; 2021 Aug; 60(8):e306-e308. PubMed ID: 33410507
    [No Abstract]   [Full Text] [Related]  

  • 20. Bupropion-induced subacute cutaneous lupus erythematosus.
    Cassis TB; Callen JP
    Australas J Dermatol; 2005 Nov; 46(4):266-9. PubMed ID: 16197429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.